Thomas Wegge

442 total citations
10 papers, 320 citations indexed

About

Thomas Wegge is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Thomas Wegge has authored 10 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Thomas Wegge's work include Nicotinic Acetylcholine Receptors Study (6 papers), Chemical synthesis and alkaloids (3 papers) and Synthesis and Biological Evaluation (3 papers). Thomas Wegge is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (6 papers), Chemical synthesis and alkaloids (3 papers) and Synthesis and Biological Evaluation (3 papers). Thomas Wegge collaborates with scholars based in Germany. Thomas Wegge's co-authors include G. SEITZ, Daniela Gündisch, Holger Gohlke, Milton T. Stubbs, B. Masjost, Ralf Schumacher, Richard A. Engh, C.B. Breitenlechner, Robert Huber and Alexander Weber and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Bone and Mineral Research.

In The Last Decade

Thomas Wegge

9 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Wegge Germany	8	197	183	55	28	26	10	320
Sushil Kumar India	11	207 1.1×	88 0.5×	36 0.7×	28 1.0×	14 0.5×	64	338
Naoto Ohkawa Japan	6	239 1.2×	142 0.8×	104 1.9×	8 0.3×	3 0.1×	8	381
Yohei Kiyotsuka Japan	13	293 1.5×	159 0.9×	28 0.5×	16 0.6×	35 1.3×	23	427
M. F. Sammons United States	9	182 0.9×	106 0.6×	21 0.4×	11 0.4×	46 1.8×	18	321
Hollis S. Kezar United States	10	241 1.2×	224 1.2×	45 0.8×	10 0.4×	5 0.2×	15	447
Yoshihito Ohtake Japan	10	320 1.6×	107 0.6×	35 0.6×	4 0.1×	56 2.2×	11	444
Danny J. Garland United States	9	273 1.4×	126 0.7×	140 2.5×	36 1.3×	26 1.0×	12	438
Gregory R. Bebernitz United States	7	199 1.0×	108 0.6×	41 0.7×	19 0.7×	11 0.4×	11	311
Shaoyi Sun China	11	283 1.4×	168 0.9×	30 0.5×	13 0.5×	14 0.5×	19	448
Matthew P. Bourbeau United States	13	302 1.5×	142 0.8×	58 1.1×	40 1.4×	5 0.2×	16	433

Countries citing papers authored by Thomas Wegge

Since Specialization

Citations

This map shows the geographic impact of Thomas Wegge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wegge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wegge more than expected).

Fields of papers citing papers by Thomas Wegge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wegge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wegge. The network helps show where Thomas Wegge may publish in the future.

Co-authorship network of co-authors of Thomas Wegge

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wegge. A scholar is included among the top collaborators of Thomas Wegge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wegge. Thomas Wegge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Rosen, David B., Burkhardt Laufer, Thomas A. Knappe, et al.. (2020). Abstract 4507: TransConTM IL-2 β/γ: a novel long-acting prodrug of receptor-biased IL-2 designed for improved pharmocokinetics and optimal activation of T cells for the treatment of cancer. Cancer Research. 80(16_Supplement). 4507–4507. 1 indexed citations

Holten-Andersen, Lars, Susanne Pihl, C.E. Rasmussen, et al.. (2019). Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism. Journal of Bone and Mineral Research. 34(11). 2075–2086. 33 indexed citations

Breitenlechner, C.B., Thomas Wegge, Ralf Schumacher, et al.. (2004). Structure-Based Optimization of Novel Azepane Derivatives as PKB Inhibitors. Journal of Medicinal Chemistry. 47(6). 1375–1390. 80 indexed citations

Gohlke, Holger, et al.. (2003). 3D QSAR Analyses-Guided Rational Design of Novel Ligands for the (α4)₂(β2)₃ Nicotinic Acetylcholine Receptor. Journal of Medicinal Chemistry. 46(11). 2031–2048. 40 indexed citations

Gohlke, Holger, et al.. (2002). Synthesis and Nicotinic Binding Studies on Enantiopure Diazine Analogues of the Novel (2-Chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165. Journal of Medicinal Chemistry. 45(5). 1064–1072. 48 indexed citations

Gündisch, Daniela, et al.. (2002). Syntheses and evaluation of pyridazine and pyrimidine Containing bioisosteres of (±)-Pyrido[3.4-b]homotropane and Pyrido-[3.4-b]tropane as novel nAChR ligands. Bioorganic & Medicinal Chemistry. 10(1). 1–9. 37 indexed citations

Gündisch, Daniela, et al.. (2001). Synthesis and evaluation of diazine containing bioisosteres of (−)-ferruginine as ligands for nicotinic acetylcholine receptors. Bioorganic & Medicinal Chemistry. 9(10). 2683–2691. 16 indexed citations

Wegge, Thomas, et al.. (2000). An alternative improved synthesis of (-)-norferruginine, a potent nAChR agonist.. PubMed. 55(10). 779–80.

Wegge, Thomas, et al.. (2000). exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: Syntheses and Nicotinic Acetylcholine Receptor Agonist Activity of Potent Pyridazine Analogues of (±)-Epibatidine. Journal of Medicinal Chemistry. 44(1). 47–57. 38 indexed citations

10.

Wegge, Thomas, et al.. (2000). A new and efficient synthetic route to enantiopure (+)-anatoxin-a from (−)-cocaine hydrochloride. Tetrahedron Asymmetry. 11(6). 1405–1410. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact